Universitätsklinikum Jena

Comprehensive genomic characterization of early-stage bladder cancer (2025) Prip F, Lamy P, Lindskrog SV, Strandgaard T, Nordentoft I, Birkenkamp-Demtröder K, Birkbak NJ, et al. Journal article Relevance of instrumented gait analysis in the prediction of the rebound phenomenon after guided growth intervention (2024) Stief F, Holder J, Braun S, Brenneis M, van Drongelen S, Byrnes SK, Layher F, et al. Journal article Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis – protocol of a German multicentre study (2024) Linse K, Weber C, Reilich P, Schöberl F, Boentert M, Petri S, Rödiger A, et al. Journal article Multispectral optoacoustic tomography of benign parotid tumors in vivo: a prospective observational pilot study (2024) Kouka M, Waldner M, Guntinas-Lichius O Journal article Recommendations for the organization of the teleconsultation service in a telestroke network (2024) Wiestler H, Zickler P, Erdur H, Abu-Mugheisib M, Kallmünzer B, Klingner C, Müller-Barna P, et al. Journal article Post-hypnotic safety suggestion improves stress coping with long-lasting effects (2024) Schmidt B, Rohleder N, Engert V Journal article T-bet+ B cells are activated by and control endogenous retroviruses through TLR-dependent mechanisms (2024) Rauch E, Amendt T, Lopez Krol A, Lang FB, Linse V, Hohmann M, Keim AC, et al. Journal article Sub-optimale Behandlung von Patienten mit Primär Biliärer Cholangitis (PBC) im klinischen Alltag der deutschen PBC Kohorte Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort (2024) Wiegand J, Franke A, Müller T, Stein K, Bantel H, Günther R, Denk G, et al. Journal article Protocol for mapping the heterogeneous dendritic cell network across the murine tissue landscape via high-dimensional flow cytometry (2024) Amon L, Seichter A, Vurnek D, Tchitashvili G, Heß I, Heger L, Lehmann C, Dudziak D Journal article Therapeutic Drug Monitoring of Long-Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection - A Case Series of Five Patients With One Virologic Failure After Development of Two-Class Resistance (2024) Gerstenberg J, Klinker H, Baier M, Von Braun A, Seybold U, Helbig C, Däumer M, et al. Journal article